Web-Based System Works Well for Diagnosis, Treatment of Recurrent Vertigo
Recurrent benign paroxysmal positional vertigo resolved for 72.4 percent of patients using web-based system
Diagnosis & Disease Information
Drop in Mortality Seen With AChEI, Memantine in Dementia With Lewy Bodies
Risk for death, unplanned hospital admission significantly lower for those taking AChEIs only or taking AChEIs and memantine
Omega-3 Fatty Acid Concentration Linked to Cognitive Function
In predominantly middle-aged cohort, higher omega-3 index linked to larger hippocampal volumes, better abstract reasoning
‘Brain-Eating Amoeba’ May Have Caused Nebraska Child’s Death
Amoeba can cause primary amebic meningoencephalitis, a brain infection that is extremely rare, but nearly always fatal
Neurological Symptoms Persist After SARS-CoV-2 Infection
Memory impairment and decreased concentration most prevalent symptoms at six-month follow-up
Amvuttra Approved for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
Amvuttra is a subcutaneously-administered RNAi therapeutic designed to block the production of wild-type and mutant transthyretin protein.
Fenfluramine Seems Effective for Lennox-Gastaut Syndrome
Reduction in frequency of drop seizures greater with fenfluramine versus placebo
Medicare Will Only Cover Aduhelm for Patients in Clinical Trials
Decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking
Enrollment Paused in Trials Evaluating BCX9930 for Complement-Mediated Diseases
BCX9930 is an investigational oral Factor D inhibitor.
Memory Deficits Seen in Individuals With ‘Long COVID’
Deficits increased with severity of ongoing self-reported symptoms; severity of initial illness did not influence later cognitive performance
